Advertisement

Topics

Tetraphase stock plummets on antibiotic failure

03:06 EST 15 Feb 2018 | PharmaTimes

Tetraphase Pharmaceuticals saw its stock plummet after revealing that a Phase III study of its experimental antibiotic eravacycline missed key targets in a late stage trial.

Original Article: Tetraphase stock plummets on antibiotic failure

NEXT ARTICLE

More From BioPortfolio on "Tetraphase stock plummets on antibiotic failure"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...